SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-20-000187
Filing Date
2020-05-05
Accepted
2020-05-05 14:57:22
Documents
41
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 03-31-2020 form_10-q.htm 10-Q 514428
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 5675
3 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3585
4 GRAPHIC angiosoma-logo.jpg GRAPHIC 12338
  Complete submission text file 0001161697-20-000187.txt   1998179

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE soan-20200331.xml EX-101.INS 270617
6 XBRL SCHEMA FILE soan-20200331.xsd EX-101.SCH 17955
7 XBRL CALCULATION FILE soan-20200331_cal.xml EX-101.CAL 29147
8 XBRL DEFINITION FILE soan-20200331_def.xml EX-101.DEF 96985
9 XBRL LABEL FILE soan-20200331_lab.xml EX-101.LAB 149707
10 XBRL PRESENTATION FILE soan-20200331_pre.xml EX-101.PRE 133002
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 20848460
SIC: 2834 Pharmaceutical Preparations